Drugs / TCM allogeneic humane central memory T cells
TCM allogeneic humane central memory T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02758223 | Apr 2016 → May 2021 | acute myeloid leukemia, myelodysplastic syndrome | Wuerzburg University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TCM allogeneic humane central memory T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02758223 ↗ |
| Modality | Cell therapy | “prophylactic adoptive transfer of donor-derived central memory T cells” NCT02758223 ↗ |
| Route | Intravenous | “Solution for injection (intravenous use)” NCT02758223 ↗ |